Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sphingoid Bases Regulate the Sigma-1 Receptor-Sphingosine and N,N'-Dimethylsphingosine Are Endogenous Agonists. | Int J Mol Sci | 2023 | 36834510 | PubTator, text mining | PubMed |
| Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells. | Cancers (Basel) | 2023 | 36831408 | PubTator, text mining | PubMed |
| Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson's Disease. | Cells | 2023 | 36831288 | PubTator, text mining | PubMed |
| Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis. | Biomedicines | 2023 | 36831084 | PubTator, text mining | PubMed |
| Mechanisms of Glucocerebrosidase Dysfunction in Parkinson's Disease. | J Mol Biol | 2023 | 36828270 | PubTator, text mining | PubMed |
| Epigenetic Changes Induced by High Glucose in Human Pancreatic Beta Cells. | J Diabetes Res | 2023 | 36815184 | PubTator, text mining | PubMed |
| Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review. | Orphanet J Rare Dis | 2023 | 36782327 | PubTator, text mining | PubMed |
| The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response. | Int J Mol Sci | 2023 | 36768427 | PubTator, text mining | PubMed |
| Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials. | Neural Regen Res | 2023 | 36751779 | PubTator, text mining | PubMed |
| A CRISPR activation screen identifies genes that enhance SARS-CoV-2 infection. | Protein Cell | 2023 | 36726758 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice. | Neurotherapeutics | 2023 | 36715870 | PubTator, text mining | PubMed |
| Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis. | Front Mol Biosci | 2023 | 36714259 | PubTator, text mining | PubMed |
| Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids. | Nat Commun | 2023 | 36709325 | PubTator, text mining | PubMed |
| Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10. | Nutrients | 2023 | 36678216 | PubTator, text mining | PubMed |
| Lipidomics-Paving the Road towards Better Insight and Precision Medicine in Rare Metabolic Diseases. | Int J Mol Sci | 2023 | 36675224 | PubTator, text mining | PubMed |
| Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases. | Int J Mol Sci | 2023 | 36674974 | PubTator, text mining | PubMed |
| The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers. | Biomolecules | 2023 | 36671552 | PubTator, text mining | PubMed |
| Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders. | Adv Drug Deliv Rev | 2023 | 36657645 | PubTator, text mining | PubMed |
| Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14). | Elife | 2023 | 36645408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=13